308 related articles for article (PubMed ID: 21270465)
21. Crystallographic determination of the disease-associated T1184R variant of complement regulator factor H.
Morgan HP; Jiang J; Herbert AP; Kavanagh D; Uhrin D; Barlow PN; Hannan JP
Acta Crystallogr D Biol Crystallogr; 2011 Jul; 67(Pt 7):593-600. PubMed ID: 21697597
[TBL] [Abstract][Full Text] [Related]
22. The effect of electrostatics on factor H function and related pathologies.
Kieslich CA; Vazquez H; Goodman GN; López de Victoria A; Morikis D
J Mol Graph Model; 2011 Aug; 29(8):1047-55. PubMed ID: 21605993
[TBL] [Abstract][Full Text] [Related]
23. Functional characterization of two novel non-synonymous alterations in CD46 and a Q950H change in factor H found in atypical hemolytic uremic syndrome patients.
Mohlin FC; Nilsson SC; Levart TK; Golubovic E; Rusai K; Müller-Sacherer T; Arbeiter K; Pállinger É; Szarvas N; Csuka D; Szilágyi Á; Villoutreix BO; Prohászka Z; Blom AM
Mol Immunol; 2015 Jun; 65(2):367-76. PubMed ID: 25733390
[TBL] [Abstract][Full Text] [Related]
24. Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome.
Frimat M; Tabarin F; Dimitrov JD; Poitou C; Halbwachs-Mecarelli L; Fremeaux-Bacchi V; Roumenina LT
Blood; 2013 Jul; 122(2):282-92. PubMed ID: 23692858
[TBL] [Abstract][Full Text] [Related]
25. Novel C3 mutation p.Lys65Gln in aHUS affects complement factor H binding.
Volokhina E; Westra D; Xue X; Gros P; van de Kar N; van den Heuvel L
Pediatr Nephrol; 2012 Sep; 27(9):1519-24. PubMed ID: 22669319
[TBL] [Abstract][Full Text] [Related]
26. Structure of complement fragment C3b-factor H and implications for host protection by complement regulators.
Wu J; Wu YQ; Ricklin D; Janssen BJ; Lambris JD; Gros P
Nat Immunol; 2009 Jul; 10(7):728-33. PubMed ID: 19503104
[TBL] [Abstract][Full Text] [Related]
27. Selective Binding of Heparin/Heparan Sulfate Oligosaccharides to Factor H and Factor H-Related Proteins: Therapeutic Potential for C3 Glomerulopathies.
Loeven MA; Maciej-Hulme ML; Yanginlar C; Hubers MC; Kellenbach E; de Graaf M; van Kuppevelt TH; Wetzels J; Rabelink TJ; Smith RJH; van der Vlag J
Front Immunol; 2021; 12():676662. PubMed ID: 34489931
[TBL] [Abstract][Full Text] [Related]
28. Structure of complement factor H carboxyl-terminus reveals molecular basis of atypical haemolytic uremic syndrome.
Jokiranta TS; Jaakola VP; Lehtinen MJ; Pärepalo M; Meri S; Goldman A
EMBO J; 2006 Apr; 25(8):1784-94. PubMed ID: 16601698
[TBL] [Abstract][Full Text] [Related]
29. An engineered construct combining complement regulatory and surface-recognition domains represents a minimal-size functional factor H.
Hebecker M; Alba-Domínguez M; Roumenina LT; Reuter S; Hyvärinen S; Dragon-Durey MA; Jokiranta TS; Sánchez-Corral P; Józsi M
J Immunol; 2013 Jul; 191(2):912-21. PubMed ID: 23772024
[TBL] [Abstract][Full Text] [Related]
30. Characterization of Binding Properties of Individual Functional Sites of Human Complement Factor H.
Haque A; Cortes C; Alam MN; Sreedhar M; Ferreira VP; Pangburn MK
Front Immunol; 2020; 11():1728. PubMed ID: 32849614
[TBL] [Abstract][Full Text] [Related]
31. Complement factor H binds at two independent sites to C-reactive protein in acute phase concentrations.
Okemefuna AI; Nan R; Miller A; Gor J; Perkins SJ
J Biol Chem; 2010 Jan; 285(2):1053-65. PubMed ID: 19850925
[TBL] [Abstract][Full Text] [Related]
32. Characterization of mutations in complement factor I (CFI) associated with hemolytic uremic syndrome.
Kavanagh D; Richards A; Noris M; Hauhart R; Liszewski MK; Karpman D; Goodship JA; Fremeaux-Bacchi V; Remuzzi G; Goodship TH; Atkinson JP
Mol Immunol; 2008 Jan; 45(1):95-105. PubMed ID: 17597211
[TBL] [Abstract][Full Text] [Related]
33. CCP1-4 of the C4b-binding protein alpha-chain are required for factor I mediated cleavage of complement factor C3b.
Blom AM; Kask L; Dahlbäck B
Mol Immunol; 2003 Jan; 39(10):547-56. PubMed ID: 12431388
[TBL] [Abstract][Full Text] [Related]
34. Critical role of the C-terminal domains of factor H in regulating complement activation at cell surfaces.
Ferreira VP; Herbert AP; Hocking HG; Barlow PN; Pangburn MK
J Immunol; 2006 Nov; 177(9):6308-16. PubMed ID: 17056561
[TBL] [Abstract][Full Text] [Related]
35. Complement factor B mutations in atypical hemolytic uremic syndrome-disease-relevant or benign?
Marinozzi MC; Vergoz L; Rybkine T; Ngo S; Bettoni S; Pashov A; Cayla M; Tabarin F; Jablonski M; Hue C; Smith RJ; Noris M; Halbwachs-Mecarelli L; Donadelli R; Fremeaux-Bacchi V; Roumenina LT
J Am Soc Nephrol; 2014 Sep; 25(9):2053-65. PubMed ID: 24652797
[TBL] [Abstract][Full Text] [Related]
36. Combining SPR with atomic-force microscopy enables single-molecule insights into activation and suppression of the complement cascade.
Makou E; Bailey RG; Johnston H; Parkin JD; Hulme AN; Hähner G; Barlow PN
J Biol Chem; 2019 Dec; 294(52):20148-20163. PubMed ID: 31719147
[TBL] [Abstract][Full Text] [Related]
37. A novel C3 mutation causing increased formation of the C3 convertase in familial atypical hemolytic uremic syndrome.
Sartz L; Olin AI; Kristoffersson AC; Ståhl AL; Johansson ME; Westman K; Fremeaux-Bacchi V; Nilsson-Ekdahl K; Karpman D
J Immunol; 2012 Feb; 188(4):2030-7. PubMed ID: 22250080
[TBL] [Abstract][Full Text] [Related]
38. Complement Genetic Variants and FH Desialylation in
Gómez Delgado I; Corvillo F; Nozal P; Arjona E; Madrid Á; Melgosa M; Bravo J; Szilágyi Á; Csuka D; Veszeli N; Prohászka Z; Sánchez-Corral P
Front Immunol; 2021; 12():641656. PubMed ID: 33777036
[TBL] [Abstract][Full Text] [Related]
39. The MFHR1 Fusion Protein Is a Novel Synthetic Multitarget Complement Inhibitor with Therapeutic Potential.
Michelfelder S; Fischer F; Wäldin A; Hörle KV; Pohl M; Parsons J; Reski R; Decker EL; Zipfel PF; Skerka C; Häffner K
J Am Soc Nephrol; 2018 Apr; 29(4):1141-1153. PubMed ID: 29335241
[TBL] [Abstract][Full Text] [Related]
40. Complement factor H-ligand interactions: self-association, multivalency and dissociation constants.
Perkins SJ; Nan R; Li K; Khan S; Miller A
Immunobiology; 2012 Feb; 217(2):281-97. PubMed ID: 22137027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
